drugset / Trial / NCT04361175
Cost Effectiveness Analysis for Induction of Ovulation in the Polycystic Ovary Syndrome by Letrozole Versus Clomiphene Citrate
RandomizedParallel-groupSingle-blindScreening
Summary
To evaluate cost effectiveness of Letrozole versus clomiphene citrate (CC) in induction of ovulation in patients with polycystic ovary syndrome.
Timeline
- Start
- 2021-03
- Primary completion
- 2021-09
- Completion
- 2021-12
Publications
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Clomiphene | Other / unclassified | 100 mg | Oral |
| Subject | Letrozole | Other / unclassified | 5 mg | Oral |